Gland Pharma IPO Detail

Business Overview

Gland Pharma established in Hyderabad, 1978 is one of the fastest growing generic injectables-focused companies by revenue in the United States from 2014 to 2019 (Source: IQVIA Report).

As on March 31, 2020 they sell their products in over 60 countries which includes USA, Europe, Canada, Australia etc.

One of their Promoters, Shanghai Fosun Pharma, is a global pharmaceutical major.

They are present in sterile injectables, oncology and ophthalmics, and focus on complex injectables, NCE-1s, First-to-File products and 505(b)(2) filings. Their delivery systems include liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags and drops.

They have 7 manufacturing facilities in India, comprising four finished formulations facilities with a total of 22 production lines and three API facilities.

As of March 31, 2020, they along with their partners had 265 ANDA filings in the United States, of which 204 were approved and 61 were pending approval.

In Fiscal Year 2020, Out of the total revenue 66.74% comes from USA and 17.74% from India.

Their total revenue from operations has grown at a CAGR of 27.38% from Fiscals 2018 to 2020. Our EBITDA has grown at a CAGR of 36.90% from Fiscals 2018 to 2020.

Company Strengths

  • Diversified B2B Model
  • Internal R&D and regulatory capabilities
  • Extensive Manufacturing Capabilities
  • Strong Growth track record with healthy cash flows

Promoters

Fosun Pharma Industrial Pte. Ltd and Shanghai Fosun Pharmaceutical (Group) Co. Ltd are the company promoters.

Financial Summary : Gland Pharma IPO

‘Fig in ‘Cr.’
 Jun’20Mar’20Mar’19Mar’18
Income
916.32772.42129.81671.7
Expenses496.31779.51423.51170.2
Profit After Tax (PAT)312.6767.6451.6320.5
EPS

20.24

49.8829.1620.72

Gland Pharma IPO Details

IPO Detail
Issue DatesNov 09 – Nov 11, 2020
Issue Size (Fresh Issue)Rs. 1250.00 Cr 
Issue Size (Offer for Sale)Rs. 5229.55 Cr
Face ValueRs. 1/- Per Share
Price BandRs. 1490 – 1500/-
Min Market Lot100 Shares
Listing PlatformNSE, BSE 
Min Investment Amt (Retail)Rs. 15,000/-
Max Investment Amt (Retail)Rs. 195,000/-

Gland Pharma IPO Schedule Table

Offer Start DateNov 09, 2020
Offer End DateNov 11, 2020
Finalisation of basis of allotmentNov 17, 2020
Initiation of RefundsNov 18, 2020
Credit of shares to Demat A/cNov 19, 2020
Listing DateNov 20, 2020

Gland Pharma IPO Registrar

Link Intime India Pvt Ltd

C-101, 247 park, LBS Marg, Vikhroli (W), Mumbai – 400083 Phone:022-49186270

Email: glandpharma.ipo@linkintime.co.in
Website: https://www.linkintime.co.in

Gland Pharma IPO Lead Manager(s)

  • Citigroup Global Markets India Pvt Ltd
  • Haitong Securities India Pvt Ltd
  • Kotak Mahindra Capital Company Ltd
  • Nomura Financial advisory & Securities (India) Pvt Ltd
0 0 vote
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x